http://addurl.nu

Tuesday, 25 September 2018

Cardiac Marker Testing Market Growth Analysis and Opportunities Forecasts Report till 2025


25 September 2018: The global cardiac marker testing market is portraying exponential growth at a high CAGR in forthcoming period due to growing incidence of cardiovascular diseases. Research on cardiac biomarkers and rising prevalence and incidence of cardiac disease are the major factors driving growth in cardiac marker testing markets. Cardiac Bio-marker diagnostic test market is used to determine the concentration of proteins also used in measuring occurrence and phase of cardiovascular disease (CVD).


Growing prevalence of cardiovascular diseases, rapidly growing geriatric population and growing funds from private-public funded organizations to conduct ongoing trials are fueling the growth of cardiac markers testing market. The major causes of CVD are smoking, high Blood Pressure, diabetes, sedentary lifestyle, unhealthy diet, high cholesterol and obesity. However, factors such as technical problems related to collection of samples and storage and issues in relation to regulatory and reimbursement systems are key factors hindering growth of the market.

Developing countries such as India and China have proved to be popular for companies developing cardiac biomarkers. Prevalence of cardiovascular diseases are significant in driving growth of cardiac biomarker testing market. China is top nation in CVD mortality rates and of importance here is that biomarkers help in early diagnosis of disease and hence help doctors and clinicians around the world with technological advances among doctors and clinicians talked in seminars are propelling demand for cardiac biomarkers in emerging markets.

Market Segment:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cardiac Marker Testing in these regions, from 2013 to 2025 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Cardiac Marker Testing market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Roche Diagnostics
• Abbott Laboratories
• Siemens
• Danaher Corporation
• Alere Inc
• BioMerieux
• LSI Medience Corporation
• Ortho Clinical Diagnostics
• Randox Laboratories Ltd
• Guangzhou Wondfo Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Chemiluminescence
• Immunofluorescence
• ELISA
• Immunochromatography

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Pharmaceutical Companies
• Reagents Manufacturers
• Imaging Instrument Providers

Table of Contents

1 Cardiac Marker Testing Market Overview
2 Global Cardiac Marker Testing Market Competition by Manufacturers
3 Global Cardiac Marker Testing Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Cardiac Marker Testing Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Cardiac Marker Testing Production, Revenue (Value), Price Trend by Type
6 Global Cardiac Marker Testing Market Analysis by Application
7 Global Cardiac Marker Testing Manufacturers Profiles/Analysis
8 Cardiac Marker Testing Manufacturing Cost Analysis
9 Global Cardiac Marker Testing Market Forecast (2018-2025)




No comments:

New Energy Vehicle Battery Market Growth Prospects and Revenue Forecast to 2023

Global new energy vehicle battery market is expected to grow significantly in the forecast period owing to high demand for passenger car...